Vital Signs: Actionable charts

Key Points: • A number of Consumer Cyclical names continue to reflect leadership. (ex. SBUX, RRGB, MCD, PZZA, and ROST.) • The Financial Sector has a number of attractive names developing major bases and staging RS reversals. (ex. SIVB, STT, AXP, SPGI, CME, GS, and JEF) • The Technology Sector has a number of technically attractive constituents. (ex. AMD, OLED, MPWR, CRUS, BR, FIS, VRSN, SAIC, LDOS, AAOI, BELFB, FARO, STX, and AAPL) .

Vital Signs: Actionable charts

Key Points: • Energy Sector names continue to develop price and RS reversals. (ex. OXY, VAL, DO, RIG, SLB, MTDR, SM, MUR, WPX, XEC, JAG, TALO, APA, DVN, and EOG) • Aero-Defense related names are reversing price and RS downtrends. (ex. AVAV, NOC, AJRD, LMT, LHX, HII, and RTN.

Vital Signs: Actionable charts

Key Points: • Homebuilders and related stocks continue to indicate a bull market. (ex. BLD, MDC, MTH, MHO, IBP, PHM, CVCO, WLH, DHI, MAS, and GFF) • The Technology Sector continues to have a number of technically attractive names that are pulling back to support levels or remain in uptrends. (ex. SEDG, FORM, KLAC, TER, AMAT, AEIS, SYNA, OLED, QRVO, CRUS, FISV, EVTC, KN, JBL, CDW, and AAPL) • Insurance and Exchange related names remain leadership in the Financial Sector (ex. CME, ICE, CB, CINF, ALL, JRVR, and RNR)

Vital Signs: Actionable charts

Key Points: • Despite weakness in a number of Consumer Discretionary stocks, there are a number of names that remain attractive (ex. KBH, PHM, SIX, RRGB, WEN, SHAK, DNKN, and WMT) • The Consumer Staples Sector continues to have a number of leadership names. (ex. HSY, K, SAFM, VGR, and CHD) • Gold remains a leadership area of the market. (ex. RGLD, and NEM) • REITs and Utilities are increasingly moving as market leadership. (ex. OHI, WELL, LTC, DEA, IRT, EQR, UDR, ADC, EXR, CONE, NSA, AMT, NEE, IDA, DUK, and ES)

Vital Signs: Actionable charts

Key Points: • A number of Restaurant names are staging price and RS reversals or continue to have bullish formations. (ex. CHUY, JACK, CMG) • There are a few healthcare related names that continue to be bright spots and reflect leadership. (ex. CUTR, TFX, BSX, SYK, ADUS, CHE, COO, WST, TRHC, HUM, AMGN, PBH, MRK, and ZTS.) • REITs continue to show leadership characteristics' as many are hitting price and RS highs. (ex. OHI, SBRA, ESS, IRT, and MAA)

Valens Equity Insights and Inflections - 2021 02 09

Current market expectations for Winnebago (WGO) still do not comprehend the company's operational tailwinds and transformation. Markets expect UAFRS-based (Uniform) ROA (ROA') to only reach prior cycle norms going forward, even as analysts are forecasting sustained ROA' improvement, in line with the company's strategy change. The company has a positive age-wave-related macro-trend likely driving fundamentals and sustained growth, thanks to more baby-boomers becoming retirees, a group that tends to be stronger buyers of RVs, spelling stronger fundamental upside. On top of that, the At-Home Rev...

CME - Embedded Expectations Analysis - 2021 02 08

CME Group Inc. (CME:USA) currently trades above corporate averages relative to UAFRS-based (Uniform) earnings, with a 40.7x Uniform P/E. At these levels, markets have bullish expectations for the firm, and management is confident about the potential of QDM 2.0, securing sales opportunities from the BrokerTec-Globex integration, and the potential of VOLQ Futures Specifically, management is confident VOLQ futures will help clients mitigate efficiencies from their other equity products and that they are converting more of their cross introductions from the BrokerTec-Globex integration into sales...

Booster shots

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

Exchange Operators: US – Q4 2020 Update: Firms end 2020 with mixed but generally positive results, and Nasdaq continues the sector’s proclivity for M&A

The four US exchange operators reported mixed but generally positive results in the fourth quarter of 2020, and Nasdaq said it would increase debt to acquire Verafin.

CME Group Inc.: Update to credit analysis following ratings' affirmation

Our credit view of CME Group, reflecting its scale, exceptional profitability, conservative debt leverage policy and heightened operational risk

Moody's affirms CME's ratings (Aa3 senior) with stable outlook

Rating Action: Moody's affirms CME's ratings with stable outlook. Global Credit Research- 16 Dec 2020. New York, December 16, 2020-- Moody's Investors Service has affirmed CME Group Inc.' s Aa3 issuer and senior unsecured ratings and its Prime-1 commercial paper rating.

Exchange Operators: US – Q3 2020 Update: Mixed results reflect pandemic’s diverse impact on product groups, but profit margins remain strong

Cboe, CME, ICE and Nasdaq had mixed results in Q3 2020, as the coronavirus continues to have differing impacts on their diversified activities, but profit margins remain strong for all

Moody's announces completion of a periodic review of ratings of CME Group Inc.

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of CME Group Inc.. Global Credit Research- 02 Sep 2020. New York, September 02, 2020-- Moody's Investors Service has completed a periodic review of the ratings of CME Group Inc. and other ratings that are associated with the same analytical unit.

CME GROUP sees an upgrade to Slightly Positive due to a better fundamental star rating

The general evaluation of CME GROUP (US), a company active in the Investment Services industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date December 29, 2020, the closing price was USD 178.86 and its potential was estimated at USD 205.96.